Silver Birch (Bet v 7) IgE

Some people get an allergy blood panel back and find themselves flagged for birch, ragweed, mugwort, plantain and plane tree all at once, with symptoms that don't follow that pattern at all. One protein may explain a good part of that list. Plants share a family of proteins called cyclophilins, and if your immune system has learned to react to one of them, it can turn up positive on tests for pollens that have never bothered you.

This test measures IgE against Bet v 7 in blood. It is a newer, research-stage allergy marker without validated diagnostic cutoffs, so it won't diagnose an allergy on its own, but it can help keep a confusing panel from steering you toward the wrong immunotherapy target.

What This Antibody Is

Bet v 7 IgE is an antibody your immune system makes after it has flagged Bet v 7 as a threat. IgE is the class of antibody behind allergic reactions. It attaches to certain immune cells, and when it meets its target those cells release the chemicals that cause sneezing, itching and swelling.

Bet v 7 is one of several proteins in silver birch pollen. It belongs to the cyclophilin family. Cyclophilins are similar across many unrelated plants, so one antibody can recognize more than one pollen. Proteins like this are called panallergens. Birch's main allergen, Bet v 1, is a different protein and accounts for most true birch pollen allergy. Bet v 7 is a minor birch allergen: when it was first described in 2000, up to about one in five birch-allergic patients recognized it.

A positive result shows sensitization: your immune system has made the antibody. Whether it causes symptoms depends on your history, when symptoms happen, and what the rest of your allergy component results show.

Pollen Results That Don't Add Up

The clearest evidence for this marker comes from a study of 253 Italian children with seasonal hay fever, and its main lesson is about diagnosis. About one in six of them (43 of 253, or 17%) had IgE against Bet v 7.

The more useful number came from a subgroup. Seventy-four children tested positive to whole birch pollen extract but had no antibody to birch's three standard components, Bet v 1, Bet v 2 and Bet v 4. Close to two thirds of them (47 of 74, or 63%) turned out to be sensitized to Bet v 7, which accounted for most of their otherwise unexplained birch result.

This goes beyond birch. Some children tested positive to ragweed, mugwort, pellitory, plantain and plane tree without antibodies to those plants' own main allergens or to the two other common panallergen families, profilins and polcalcins. Their antibody levels to those pollens tracked with their Bet v 7 IgE, and adding Bet v 7 to their blood samples blocked between 45% and 74% of the antibody binding to the other extracts.

What this means for you: if your panel shows a long list of loosely related pollens, a positive Bet v 7 result suggests at least part of that list comes from one shared protein. Whole-extract skin prick tests and whole-extract blood tests can both be misled this way, which is why the researchers recommended adding cyclophilins to molecular allergy testing.

Asthma and Food Reactions

In the same children, Bet v 7 sensitization first looked linked to asthma and oral allergy syndrome. Oral allergy syndrome often means itching or swelling in the mouth or throat after raw fruits or vegetables. After the researchers adjusted for IgE to the PR-10 family (the group that includes Bet v 1), profilins and lipid transfer proteins, both links disappeared.

A newer functional study selected 100 children from the same cohort and found that Bet v 7 IgE tracked almost perfectly with IgE to Ara h 18, a peanut cyclophilin. In lab experiments, some patient blood samples activated mast cells when exposed to Bet v 7, and the response grew with the dose. Mast cells are immune cells that release allergy chemicals. The protein also held up to mild heating and to saliva digestion. That gives Bet v 7 biological plausibility, but it still doesn't prove that a positive blood result predicts peanut or food reactions.

Those findings fit together once you see Bet v 7 as a marker of breadth. Children who react to many pollen proteins are the ones more likely to have asthma, and Bet v 7 tends to show up in that group without proving it is the driver. Most established pollen-food decisions still run through Bet v 1 and related food proteins in apple, cherry, hazelnut, soy and other plant foods. Bet v 7 food links are plausible but not settled.

So read a positive result as a sign of how widely your immune system reacts to plant proteins. On its own it doesn't diagnose asthma or food allergy.

Sensitized Isn't the Same as Allergic

Having IgE against a protein and reacting to that protein are two different things. In studies of the main birch allergen, blood antibody levels lined up poorly with skin reactions and with how strongly immune cells responded in a test tube. Plenty of sensitized people never have symptoms, and the antibody level alone can't sort them from the people who do.

For a panallergen the gap is wider still. A positive result tells you the antibody exists. Your symptoms, when they happen in the pollen year, and your major component results are what tell you whether it's causing trouble.

When Results Can Be Misleading

Almost nothing has been studied about what distorts Bet v 7 IgE itself. The strongest caution comes from allergy testing in general: platform matters.

• Testing platform: most published Bet v 7 data used recombinant Bet v 7 in research or multiplex settings. Single-allergen blood tests, multi-allergen chips and skin tests can pick up panallergens differently, and two chip platforms gave different panallergen results on the same patients. Don't compare platforms as if they were the same test.
• Recent pollen exposure: specific IgE can rise after nasal allergen exposure. A pilot study using Bet v 1 raised Bet v 1 IgE, not Bet v 7 IgE, so season-to-season changes in this result should be read carefully.
• Steroid tablets: small asthma studies found that prednisone can raise total IgE during treatment. Bet v 7 IgE was not studied, but recent steroid courses are worth noting when you compare results.
• Anti-IgE drugs: omalizumab and similar drugs change free and total IgE and can affect some IgE assays. Some ImmunoCAP allergen-specific results may remain analytically reliable, but don't compare results on and off therapy without noting it.

Tracking Your Trend

No one has measured how much Bet v 7 IgE naturally drifts within one person, so there's no validated figure for how large a change has to be before it means something. For IgE generally the swings can be sizable. In the placebo group of an anti-IgE trial, free IgE varied by about a quarter within the same person with no treatment at all.

That makes a single result a snapshot. If you retest, use the same lab and compare samples drawn in a similar part of the pollen year.

The lack of standardized cutoffs is a reason to keep the result in context. As the science matures, your own history will matter more than any single number.

What to Do With Your Result

This result is most useful read next to the rest of your birch components, with Bet v 1 IgE as the anchor. Many studies find that Bet v 1 identifies most true birch pollen allergy, often above 90%, but performance varies by region and by how allergy was defined. The patterns below show how the pieces combine.

• Bet v 7 positive, Bet v 1 negative: your positive birch result probably comes from cyclophilin cross-reactivity. Birch immunotherapy extracts are built around Bet v 1 content, so starting birch allergy shots on this pattern has a weaker rationale, and the plant that matches your symptom timing deserves a closer look.
• Both positive: you likely have true birch allergy plus broader sensitization. Bet v 1 drives decisions about birch immunotherapy and classic pollen-food cross-reactions, while Bet v 7 helps explain extra positives on other pollens.
• Bet v 7 negative, but a puzzling multi-pollen panel: check the profilins (Bet v 2, Phl p 12) and polcalcins (Bet v 4, Phl p 7), the other common panallergen families.
• Positive with no symptoms: this is sensitization without disease and needs no treatment. In a three-year study of adults, symptom-free birch skin-test sensitization predicted later birch allergy, especially when birch IgE and skin test reactions were larger. That study was not specific to Bet v 7, so repeat your panel if symptoms start.

Bring in an allergist when you're weighing immunotherapy, when asthma is part of the picture, or when you've reacted to foods. Those decisions need an exam and a full history, and a component pattern like yours is exactly what an allergist will want to see.